PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Bendroflumethiazide
Presentation Product Chemical substance Chapter Items dispensed
Bendroflumethiazide 2.5mg tablets
0202010B0AAABAB
Bendroflumethiazide Bendroflumethiazide Cardiovascular System 1,118,314
Bendroflumethiazide 5mg tablets
0202010B0AAACAC
Bendroflumethiazide Bendroflumethiazide Cardiovascular System 45,989
Bendroflumethiazide 2.5mg/5ml oral suspension
0202010B0AAAXAX
Bendroflumethiazide Bendroflumethiazide Cardiovascular System 168
Bendroflumethiazide 1.25mg/5ml oral suspension
0202010B0AAAUAU
Bendroflumethiazide Bendroflumethiazide Cardiovascular System 6
Bendroflumethiazide 5mg/5ml oral suspension
0202010B0AAAQAQ
Bendroflumethiazide Bendroflumethiazide Cardiovascular System 1
Bendroflumethiazide 1mg/5ml oral suspension
0202010B0AAAWAW
Bendroflumethiazide Bendroflumethiazide Cardiovascular System No data available
Bendroflumethiazide 2mg/5ml oral liquid
0202010B0AAASAS
Bendroflumethiazide Bendroflumethiazide Cardiovascular System No data available
Bendroflumethiazide 3.75mg/5ml oral liquid
0202010B0AAAVAV
Bendroflumethiazide Bendroflumethiazide Cardiovascular System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.